Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HRMY
#1797
Harmony Biosciences Holdings, Inc. Common Stock
28.540
0
+0.25%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.25%
Monthly Change
-24.24%
6 month change
-7.64%
Year Change
-7.64%
Previous Close
28.470
0
Open
28.540
0
Bid
Ask
Low
28.540
0
High
28.540
0
Volume
110
Markets
US Stock Market
Healthcare
HRMY
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
57.03 M
57.35 M
57.42 M
57.53 M
57.6 M
57.84 M
—
Valuation ratios
Enterprise value
1.89 B
1.52 B
1.42 B
1.27 B
940.36 M
1.41 B
5.04 B
Price to earnings ratio
18.87
13.71
12.67
10.19
8.67
13.81
45.34
Price to sales ratio
3.42
2.79
2.58
2.38
1.95
2.52
9.44
Price to cash flow ratio
10.63
9.06
8.64
7.09
5.41
6.29
27.43
Price to book ratio
1.1
3.02
0.77
0.67
0.54
2.52
4.49
Enterprise value to EBITDA ratio
8.78
7.12
6.02
4.85
3.53
6.1
20.5
Profitability ratios
Return on assets %
0.05
0.05
0.04
0.04
0.04
0.02
0.14
Return on equity %
0.08
0.08
0.06
0.05
0.06
0.03
0.2
Return on invested capital %
41.64
43.28
36.37
29.77
39.61
19.07
124.81
Gross margin %
77.01
72.97
82.68
80.97
75.09
71.88
310.62
Operating margin %
33.17
27.69
30.45
24.03
27.35
15.82
97.64
EBITDA margin %
36.18
39.38
33.52
26.86
29.77
25.55
115.7
Net margin %
24.78
24.58
24.66
19.84
21.24
9.22
74.97
Liquidity ratios
Quick ratio
3.2
3.27
3.63
3.8
3.72
3.58
14.74
Current ratio
3.24
3.31
3.67
3.84
3.75
3.6
14.86
Inventory turnover
6.81
7.71
4.71
6.11
9.19
11.2
31.21
Asset turnover
0.21
0.21
0.18
0.19
0.21
0.2
0.77
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.18
0.16
0.15
0.14
0.12
0.11
0.52
Long term debt to total equity ratio
0.28
0.25
0.22
0.2
0.18
0.17
0.76
Per share metrics
Operating cash flow per share
1.21
1.31
0.58
1.36
1.85
2.15
5.95
EBIT per share
1.06
0.96
0.96
0.82
1.12
0.66
3.56
EBITDA per share
1.16
1.37
1.06
0.92
1.21
1.06
4.26
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.06
8.07
8.66
9.67
11.45
13.24
43.04
Net current asset value per share
8.99
10.01
10.98
11.83
14.29
15.49
52.59
Tangible book value per share
8.22
9.43
10.48
11.5
12.6
13.34
47.91
Working capital per share
6.22
6.98
7.99
8.75
10.48
11.19
38.41
Book value per share
10.27
11.39
12.31
13.23
14.22
14.86
54.63
News
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y
IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Corcept's Q4 Earnings and Revenues Fall Short of Estimates
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target
AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales
BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market
Harmony Bio Q4 2025 slides: path to $1B revenue amid profit pressures
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates